|Articles|March 1, 2020
- Pharmaceutical Executive-03-01-2020
- Volume 40
- Issue 3
Pharmaceutical Executive, March 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
The Multichannel Reach: Balancing the Local and Global Voiceover 5 years ago
Market Access: From Being to Becomingover 5 years ago
Consider Data Before It’s a Problemover 5 years ago
Multichannel Marketing: Integrating Omnichannelover 5 years ago
Feds Target Biosimilar Anticompetitive Practicesover 5 years ago
Blood Feud Divides Europe Over Plasma Shortfallsover 5 years ago
Social Media’s Influence in Messaging Mixover 5 years ago
Habib Bennaceur: Following the Sciencealmost 6 years ago
A Bad Deal with Data?almost 6 years ago
Country Report: United Arab EmiratesNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
